180 related articles for article (PubMed ID: 27127104)
1. Putative role of 5-HT
Segelcke D; Messlinger K
Cephalalgia; 2017 Apr; 37(4):365-371. PubMed ID: 27127104
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia facilitates neurogenic dural plasma protein extravasation in mice: a novel animal model for migraine pathophysiology.
Hunfeld A; Segelcke D; Bäcker I; Mecheri B; Hemmer K; Dlugosch E; Andriske M; Paris F; Zhu X; Lübbert H
Sci Rep; 2015 Dec; 5():17845. PubMed ID: 26644235
[TBL] [Abstract][Full Text] [Related]
3. Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation.
Johnson KW; Nelson DL; Dieckman DK; Wainscott DB; Lucaites VL; Audia JE; Owton WM; Phebus LA
Cephalalgia; 2003 Mar; 23(2):117-23. PubMed ID: 12603368
[TBL] [Abstract][Full Text] [Related]
4. Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache?
Schmuck K; Ullmer C; Kalkman HO; Probst A; Lubbert H
Eur J Neurosci; 1996 May; 8(5):959-67. PubMed ID: 8743744
[TBL] [Abstract][Full Text] [Related]
5. Serotonin in migraine: theories, animal models and emerging therapies.
Johnson KW; Phebus LA; Cohen ML
Prog Drug Res; 1998; 51():219-44. PubMed ID: 9949863
[TBL] [Abstract][Full Text] [Related]
6. BF-1--a novel selective 5-HT2B receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs.
Schmitz B; Ullmer C; Segelcke D; Gwarek M; Zhu XR; Lübbert H
Eur J Pharmacol; 2015 Mar; 751():73-80. PubMed ID: 25666387
[TBL] [Abstract][Full Text] [Related]
7. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
Peroutka SJ
Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
[TBL] [Abstract][Full Text] [Related]
8. Neurogenic inflammation in the context of migraine.
Williamson DJ; Hargreaves RJ
Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
10. Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.
Schaerlinger B; Hickel P; Etienne N; Guesnier L; Maroteaux L
Br J Pharmacol; 2003 Sep; 140(2):277-84. PubMed ID: 12970106
[TBL] [Abstract][Full Text] [Related]
11. [Effect of tropoxin on cerebrovascular effects of meta-chlorophenylpiperazine and serotonin].
Gorbunov AA; Gan'shina TS; Mirzoian RS
Eksp Klin Farmakol; 2010 Sep; 73(9):13-6. PubMed ID: 21086646
[TBL] [Abstract][Full Text] [Related]
12. Peripheral and central activation of trigeminal pain pathways in migraine: data from experimental animal models.
Buzzi MG; Tassorelli C; Nappi G
Cephalalgia; 2003; 23 Suppl 1():1-4. PubMed ID: 12699454
[TBL] [Abstract][Full Text] [Related]
13. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
14. Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine.
May A; Shepheard SL; Knorr M; Effert R; Wessing A; Hargreaves RJ; Goadsby PJ; Diener HC
Brain; 1998 Jul; 121 ( Pt 7)():1231-7. PubMed ID: 9679775
[TBL] [Abstract][Full Text] [Related]
15. Migraine.
Benemei S; Nicoletti P; Capone JG; De Cesaris F; Geppetti P
Handb Exp Pharmacol; 2009; (194):75-89. PubMed ID: 19655105
[TBL] [Abstract][Full Text] [Related]
16. The pathophysiology of migraine: year 2005.
Buzzi MG; Moskowitz MA
J Headache Pain; 2005 Jun; 6(3):105-11. PubMed ID: 16355290
[TBL] [Abstract][Full Text] [Related]
17. The trigemino-vascular system and migraine.
Buzzi MG; Moskowitz MA
Pathol Biol (Paris); 1992 Apr; 40(4):313-7. PubMed ID: 1379707
[TBL] [Abstract][Full Text] [Related]
18. The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptors.
Gupta S; Villalón CM
Pharmacol Ther; 2010 Oct; 128(1):170-90. PubMed ID: 20655327
[TBL] [Abstract][Full Text] [Related]
19. Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.
Akerman S; Holland PR; Hoffmann J
Cephalalgia; 2013 Jun; 33(8):577-92. PubMed ID: 23671254
[TBL] [Abstract][Full Text] [Related]
20. Investigations into migraine pathogenesis: time course for effects of m-CPP, BW723C86 or glyceryl trinitrate on appearance of Fos-like immunoreactivity in rat trigeminal nucleus caudalis (TNC).
Martin RS; Martin GR
Cephalalgia; 2001 Feb; 21(1):46-52. PubMed ID: 11298663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
